Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Economic implications of cardiovascular disease management programs: moving beyond one-off experiments
Author: Maru, S.
Byrnes, J.
Carrington, M.
Stewart, S.
Scuffham, P.
Citation: Expert Review of Pharmacoeconomics and Outcomes Research, 2015; 15(4):657-666
Publisher: Taylor & Francis
Issue Date: 2015
ISSN: 1473-7167
Statement of
Shoko Maru, Joshua Byrnes, Melinda J Carrington, Simon Stewart and Paul A Scuffham
Abstract: Substantial variation in economic analyses of cardiovascular disease management programs hinders not only the proper assessment of cost-effectiveness but also the identification of heterogeneity of interest such as patient characteristics. The authors discuss the impact of reporting and methodological variation on the cost-effectiveness of cardiovascular disease management programs by introducing issues that could lead to different policy or clinical decisions, followed by the challenges associated with net intervention effects and generalizability. The authors conclude with practical suggestions to mitigate the identified issues. Improved transparency through standardized reporting practice is the first step to advance beyond one-off experiments (limited applicability outside the study itself). Transparent reporting is a prerequisite for rigorous cost-effectiveness analyses that provide unambiguous implications for practice: what type of program works for whom and how.
Keywords: Cardiovascular disease; cost-effectiveness; disease management; economic evaluation; heart failure
Rights: © 2015 Informa UK Ltd
RMID: 0030087258
DOI: 10.1586/14737167.2015.1046842
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.